详情页 - 聚合机构库演示平台

资源类型：

文章类型：

作者：

Shen, Yuanming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] * ; Kong, Beihua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Xia, Bairong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Wang, Fei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]

; Yin, Rutie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Li, Qingshui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Yue, Ying[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Kang, Shan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; He, Liping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Wang, Ke[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]

; Meng, Yuanguang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Wang, Shixuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]

; Qu, Pengpeng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Huang, Xianghua[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Guo, Ruixia[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Yan, Ping[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Pan, Mei[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Lou, Ge[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Cheng, Wenjun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ; Xie, Xing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21] ;

单位： [1]Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China [2]Shandong Univ, Qilu Hosp, Jinan, Peoples R China [3]Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Hefei, Peoples R China [4]Shandong Prov Hosp, Jinan, Peoples R China [5]Sichuan Univ, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China [6]Shandong Canc Hosp & Inst, Jinan, Peoples R China [7]Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China [8]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [9]Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China [10]Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Guizhou, Peoples R China [11]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China [12]Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China [13]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [14]Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China [15]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China [16]Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China [17]Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China [18]Maternal & Child Hlth Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China [19]Harbin Med Univ, Canc Hosp, Harbin, Heilongjiang, Peoples R China [20]Jiangsu Prov Hosp, Nanjing, Peoples R China [21]Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2021]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者单位： [1]Zhejiang Univ, Sch Med, Womens Hosp, Hangzhou, Zhejiang, Peoples R China [2]Shandong Univ, Qilu Hosp, Jinan, Peoples R China [3]Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp 1, Hefei, Peoples R China [4]Shandong Prov Hosp, Jinan, Peoples R China [5]Sichuan Univ, West China Univ Hosp 2, Chengdu, Sichuan, Peoples R China [6]Shandong Canc Hosp & Inst, Jinan, Peoples R China [7]Jilin Univ, Affiliated Hosp 1, Changchun, Peoples R China [8]Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China [9]Hebei Tumor Hosp, Shijiazhuang, Hebei, Peoples R China [10]Guizhou Med Univ, Affiliated Canc Hosp, Guiyang, Guizhou, Peoples R China [11]Tianjin Med Univ Canc Inst & Hosp, Tianjin, Peoples R China [12]Chinese Peoples Liberat Army Gen Hosp, Dept Gynecol & Obstet, Beijing, Peoples R China [13]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [14]Tianjin Cent Hosp Gynecol & Obstet, Tianjin, Peoples R China [15]Hebei Med Univ, Hosp 2, Shijiazhuang, Hebei, Peoples R China [16]Zhengzhou Univ, Affiliated Hosital 1, Zhengzhou, Peoples R China [17]Hebei Gen Hosp, Shijiazhuang, Hebei, Peoples R China [18]Maternal & Child Hlth Hosp Jiangxi Prov, Nanchang, Jiangxi, Peoples R China [19]Harbin Med Univ, Canc Hosp, Harbin, Heilongjiang, Peoples R China [20]Jiangsu Prov Hosp, Nanjing, Peoples R China [21]Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial

文献详情